PL1814572T3 - Depsypeptydy stosowane do zapobiegania wertykalnym zakażeniom endopasożytami - Google Patents

Depsypeptydy stosowane do zapobiegania wertykalnym zakażeniom endopasożytami

Info

Publication number
PL1814572T3
PL1814572T3 PL05800013T PL05800013T PL1814572T3 PL 1814572 T3 PL1814572 T3 PL 1814572T3 PL 05800013 T PL05800013 T PL 05800013T PL 05800013 T PL05800013 T PL 05800013T PL 1814572 T3 PL1814572 T3 PL 1814572T3
Authority
PL
Poland
Prior art keywords
depsipeptides
prevention
vertical
endoparasite infections
infections
Prior art date
Application number
PL05800013T
Other languages
English (en)
Inventor
Thomas Bach
Janina Tänzler
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL1814572T3 publication Critical patent/PL1814572T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
PL05800013T 2004-11-16 2005-11-03 Depsypeptydy stosowane do zapobiegania wertykalnym zakażeniom endopasożytami PL1814572T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004055316A DE102004055316A1 (de) 2004-11-16 2004-11-16 Verhinderung vertikaler Endoparasiten-Infektionen
PCT/EP2005/011748 WO2006053641A1 (de) 2004-11-16 2005-11-03 Verhinderung vertikaler endoparasiten-infektionen
EP05800013A EP1814572B1 (de) 2004-11-16 2005-11-03 Depsipeptide zur verhinderung vertikaler endoparasiten-infektionen

Publications (1)

Publication Number Publication Date
PL1814572T3 true PL1814572T3 (pl) 2010-11-30

Family

ID=35767587

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05800013T PL1814572T3 (pl) 2004-11-16 2005-11-03 Depsypeptydy stosowane do zapobiegania wertykalnym zakażeniom endopasożytami

Country Status (29)

Country Link
US (1) US20090215678A1 (pl)
EP (1) EP1814572B1 (pl)
JP (1) JP5078619B2 (pl)
KR (1) KR101280511B1 (pl)
CN (1) CN101102785B (pl)
AR (1) AR052133A1 (pl)
AT (1) ATE469652T1 (pl)
AU (1) AU2005306070B2 (pl)
BR (1) BRPI0518172A (pl)
CA (1) CA2587537C (pl)
CR (1) CR9108A (pl)
DE (2) DE102004055316A1 (pl)
DK (1) DK1814572T3 (pl)
ES (1) ES2345265T3 (pl)
HR (1) HRP20100471T1 (pl)
IL (1) IL183200A (pl)
MX (1) MX2007005766A (pl)
MY (1) MY142727A (pl)
NO (1) NO341472B1 (pl)
NZ (1) NZ555117A (pl)
PE (1) PE20061079A1 (pl)
PL (1) PL1814572T3 (pl)
PT (1) PT1814572E (pl)
RU (1) RU2405565C2 (pl)
SI (1) SI1814572T1 (pl)
TW (1) TWI358293B (pl)
UA (1) UA91694C2 (pl)
WO (1) WO2006053641A1 (pl)
ZA (1) ZA200703982B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
KR101978620B1 (ko) * 2011-12-21 2019-08-28 바이엘 파마 악티엔게젤샤프트 무정형 에모뎁시드를 함유하는 제제
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
PL3676265T3 (pl) 2017-11-07 2025-12-15 Elanco Animal Health Gmbh Sposób syntezy cyklicznych depsypeptydów

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
DK0634408T3 (da) * 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
CN1073560C (zh) * 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
ES2095772T3 (es) * 1993-05-05 1997-02-16 Palo Alto Medical Found Utilizacion de derivados de rifamicina para producir un medicamento destinado al tratamiento de la toxoplasmosis.
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
EP0718293B1 (en) * 1993-09-06 2002-03-13 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) * 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) * 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
EP0872481B1 (en) * 1995-06-30 2009-03-18 Astellas Pharma Inc. Depsipeptide derivative, process for production thereof, and novel intermediate therefor
DE69634961T2 (de) * 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
US20010036922A1 (en) * 2000-04-03 2001-11-01 Benchaoui Hafid Abdelaali Method of treating a parasitic infection
GB0008353D0 (en) * 2000-04-03 2000-05-24 Pfizer Ltd Method of treating a parasitic infection
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
KR101280511B1 (ko) 2013-07-01
HK1117041A1 (en) 2009-01-09
IL183200A0 (en) 2007-08-19
CN101102785A (zh) 2008-01-09
ATE469652T1 (de) 2010-06-15
JP2008520598A (ja) 2008-06-19
CN101102785B (zh) 2011-05-18
HRP20100471T1 (hr) 2010-10-31
AU2005306070A1 (en) 2006-05-26
JP5078619B2 (ja) 2012-11-21
ES2345265T3 (es) 2010-09-20
UA91694C2 (ru) 2010-08-25
PT1814572E (pt) 2010-08-02
DE102004055316A1 (de) 2006-05-18
NO341472B1 (no) 2017-11-20
SI1814572T1 (sl) 2010-09-30
MX2007005766A (es) 2007-07-16
TW200626140A (en) 2006-08-01
EP1814572A1 (de) 2007-08-08
NO20073023L (no) 2007-08-10
AU2005306070B2 (en) 2011-05-12
TWI358293B (en) 2012-02-21
MY142727A (en) 2010-12-31
WO2006053641A1 (de) 2006-05-26
ZA200703982B (en) 2008-08-27
DK1814572T3 (da) 2010-09-20
NZ555117A (en) 2009-11-27
RU2007122284A (ru) 2008-12-27
KR20070084412A (ko) 2007-08-24
AR052133A1 (es) 2007-03-07
RU2405565C2 (ru) 2010-12-10
CA2587537A1 (en) 2006-05-26
DE502005009697D1 (de) 2010-07-15
CA2587537C (en) 2014-06-03
PE20061079A1 (es) 2006-11-30
IL183200A (en) 2011-12-29
EP1814572B1 (de) 2010-06-02
CR9108A (es) 2007-09-11
BRPI0518172A (pt) 2008-11-04
US20090215678A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
IL183689A (en) Pharmaceutical compositions for improving the structure and function of arterioles
GB0419849D0 (en) Pharmaceutical combination
IL177480A0 (en) Pharmaceutical composition
ZA200702418B (en) Taste-masking Pharmaceutical compositions
PT1701698E (pt) Composição farmacêutica para a administração oral de cci-779
ZA200703982B (en) Prevention of vertical endoparasite infections
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
EP1778252A4 (en) NON-CARDIOTOXIC PHARMACEUTICAL COMPOUNDS
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
GB0425255D0 (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
IL177735A0 (en) Combined pharmaceutical composition for the inhibition of the decline of cognitive functions
IL180487A0 (en) Medicament
GB0424742D0 (en) Pharmaceutical compounds
ZA200701931B (en) Pharmaceutical composition
IL183518A0 (en) Novel pharmaceutical composition useful for vaccines
GB0417777D0 (en) Pharmaceutical combination
GB0426942D0 (en) Medicament
GB0409098D0 (en) Medicament
GB0402799D0 (en) Pharmaceutical composition
ZA200704859B (en) Pharmaceutical compositions for the treatment of cellulite
SI1701698T1 (sl) Neposredno stisljiv farmacevtski sestavek za peroralno dajanje CCI-779